Takeda Pharmaceutical Co. Ltd (TAK)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:859
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q1  2026
Richard Pzena - Pzena Investment Management Add 37.49% 7,733 0.00
Q4  2025
Richard Pzena - Pzena Investment Management Buy 20,627 0.00
Q1  2025
Sarah Ketterer - Causeway Capital Management Sell 100.00% 522,030 0.16
Q4  2024
Sarah Ketterer - Causeway Capital Management Reduce 59.25% 759,162 0.23
Q3  2024
Sarah Ketterer - Causeway Capital Management Reduce 5.39% 72,972 0.03
Q2  2024
Sarah Ketterer - Causeway Capital Management Reduce 6.28% 90,744 0.03
Q1  2024
Sarah Ketterer - Causeway Capital Management Add 7.38% 99,263 0.04
Q4  2023
Sarah Ketterer - Causeway Capital Management Add 8.14% 101,336 0.04
Q3  2023
Sarah Ketterer - Causeway Capital Management Add 11.04% 123,725 0.05
Q2  2023
Sarah Ketterer - Causeway Capital Management Reduce 0.78% 8,782 0.00
Q1  2023
Sarah Ketterer - Causeway Capital Management Reduce 15.09% 200,676 0.08
Q1  2020
Lee Ainslie - Maverick Capital Sell 100.00% 716,145 0.21
Q4  2019
Lee Ainslie - Maverick Capital Reduce 6.31% 48,256 0.01
Seth Klarman - Baupost Group Sell 100.00% 9,434,803 1.91
Q3  2019
Seth Klarman - Baupost Group Reduce 0.03% 3,200 0.00
Lee Ainslie - Maverick Capital Reduce 54.58% 918,487 0.23
Q2  2019
Lee Ainslie - Maverick Capital Reduce 3.37% 58,778 0.02
Seth Klarman - Baupost Group Reduce 11.54% 1,231,018 0.20
Q1  2019
Lee Ainslie - Maverick Capital Add 352.38% 1,356,666 0.37
Seth Klarman - Baupost Group Buy 10,669,021 1.88
Q4  2018
Lee Ainslie - Maverick Capital Buy 385,000 0.10

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.